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Background: The Southeastern United States has the lowest kidney transplant rates in the nation, and racial
disparities in kidney transplant access are concentrated in this region. The Southeastern Kidney Transplant Coalition
(SEKTC) of Georgia, North Carolina, and South Carolina is an academic and community partnership that was formed
with the mission to improve access to kidney transplantation and reduce disparities among African American (AA)
end stage renal disease (ESRD) patients in the Southeastern United States.
Methods/Design: We describe the community-based participatory research (CBPR) process utilized in planning the
Reducing Disparities In Access to kidNey Transplantation (RaDIANT) Community Study, a trial developed by the
SEKTC to reduce health disparities in access to kidney transplantation among AA ESRD patients in Georgia, the state
with the lowest kidney transplant rates in the nation. The SEKTC Coalition conducted a needs assessment of the
ESRD population in the Southeast and used results to develop a multicomponent, dialysis facility-randomized,
quality improvement intervention to improve transplant access among dialysis facilities in GA. A total of 134 dialysis
facilities are randomized to receive either: (1) standard of care or “usual” transplant education, or (2) the multicomponent
intervention consisting of transplant education and engagement activities targeting dialysis facility leadership, staff, and
patients within dialysis facilities. The primary outcome is change in facility-level referral for kidney transplantation from
baseline to 12 months; the secondary outcome is reduction in racial disparity in transplant referral.
Discussion: The RaDIANT Community Study aims to improve equity in access to kidney transplantation for ESRD
patients in the Southeast.
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For the majority of the more than 600,000 patients in the
United States (US) with end stage renal disease (ESRD)
[1], kidney transplantation is the preferred treatment,
providing longer survival, better quality of life, lower
hospitalization rates, and substantial cost savings com-
pared to dialysis [2,3]. Despite these benefits, kidney trans-
plantation is not available to all ESRD patients due to the
paucity of available organs as well as long-standing racial
disparities in access to both living donor (LD) and de-
ceased donor (DD) transplantation [4-7]. Racial disparities
in kidney transplant access are concentrated in the South-
eastern US [4,6,8], where African American (AA) patients
represent 67% of the prevalent ESRD population and
where LD and DD transplant rates are the lowest in the
nation [9,10]. Targeting the ESRD regions with the most
racial disparity in access to kidney transplantation could
reduce the overall racial disparity in access to kidney
transplantation [11]. However, despite numerous studies
showing consistent racial disparities in access to trans-
plantation, few interventions have been implemented to
reduce disparities in the transplant process [12].
Our Southeastern Kidney Transplant Coalition (SEKTC)
was formed in 2010 with the help of ESRD Network 6
(Southeastern Kidney Council) with a mission of improv-
ing equity in access to kidney transplantation for ESRD pa-
tients in the Southeast, particularly Georgia (GA), North
Carolina (NC), and South Carolina (SC). This group con-
sists of voluntary stakeholders in the ESRD community, in-
cluding ESRD patients, dialysis facilities, transplant centers,
social workers, organ procurement organizations, health-
care providers, academic researchers, patient advocacy
groups within the tri-state region, and ESRD Network 6
staff.
At our inaugural SEKTC face-to-face meeting in
February 2011, our SEKTC partners utilized a standard
quality improvement approach to discuss root causes of
delayed access to kidney transplantation in the Southeast
to help inform the development of a multicomponent,
quality improvement intervention [13]. A variety of
patient-, provider-, dialysis facility-, neighborhood-, and
health systems-level factors were identified as major
barriers for the primarily AA ESRD patient population
in the Southeast. These included: patient factors, such
as lower income [14,15], education [5], access to health-
care [16], education [5], medical comorbidities [17,18], low
health literacy [19], cultural beliefs and patient preferences
[20-27], and limited social networks [28-30]; provider fac-
tors, such as misconceptions that AA patients do better on
dialysis compared to transplant [23,31-36], lack of edu-
cation about kidney disease and the transplant process
[37,38], lack of information about the risks and benefits of
treatment options among both patients and providers
[31,32], and provider bias [39-41]; and system-level factors,such as policies resulting in delays in access or outcomes
on the basis of race, ethnicity, or socioeconomic status and
non-standardized requirements for patient-provider dis-
cussions about transplantation [42].
The SEKTC members recognized significant gaps in
our knowledge about the reasons for low kidney trans-
plantation rates among AA ESRD patients in the South-
eastern region. Our primary limitation was the lack of
surveillance data on key steps in the transplantation
process including lack of information on providers gen-
erating transplant referrals, provider perceptions on kid-
ney transplantation, and patient-reported barriers to
transplantation in the Southeast. Coalition members
formed subgroup committees to address these gaps and,
throughout the following 18 months, performed qualita-
tive and quantitative research to improve our understand-
ing of the challenges within the transplantation process in
the Southeast. Detailed results from this population needs
assessment [43-46] are described elsewhere, but we de-
scribe these results in brief below since these results influ-
enced the development of multi-component intervention
activities for the Reducing Disparities In Access to kidNey
Transplantation (RaDIANT) Community Study.
Quantitative analyses of the Dialysis Facility Report data
revealed significant variability in transplant rates across
dialysis units in Network 6, where 80% of dialysis facilities
were performing below the national average. Among the
three states in ESRD Network 6, GA had the lowest kidney
transplant rates, which were also the lowest rates in the
entire nation [9]. Other quantitative analysis involved data
from a dialysis-facility survey administered through our
community partners. Results from this survey of more
than 500 dialysis facility providers in GA, NC, and SC
found that almost all providers (98.4%) reported they were
comfortable discussing kidney transplantation with
patients. However, most staff reported that >50% of their
patients were not interested in transplantation [44]. Ap-
proximately 30% of providers believed that they did not
have sufficient training about transplantation and did not
have sufficient patient educational resources (33%) [44].
Qualitative research involved focus groups conducted
among 40 ESRD patients from GA, NC, and SC. Most pa-
tients were interested in kidney transplantation, although
many patients were confused about the kidney transplant-
ation process. Common patient barriers derived from
these focus groups included financial concerns, medical
barriers, limited social network of transplant successes,
and lack of information and education on transplantation
within the dialysis facility [43].
The results of this population needs assessment helped
our SEKTC partners to develop the multicomponent inter-
vention activities. Specifically, the quantitative analyses that
identified GA as the state with the lowest kidney transplant
rates motivated our SEKTC to focus intervention activities
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transplantation across dialysis facilities suggested the need
for traditional quality improvement methods for low per-
forming dialysis facilities, including facility protocols to en-
sure best practices for kidney transplant referral. Dialysis
facility surveys showed that targeted education among dia-
lysis facility staff was needed, based on staff survey results
showing that a third of providers felt they did not have suf-
ficient patient educational resources and did not have suffi-
cient training about transplantation. Focus group analyses
suggested that patients had limited knowledge about the
kidney transplant process and few educational resources or
tools to help clarify misinformation or lacking information.
The results of this needs assessment, combined with
practical aspects such as sustainability and feasibility,
helped the SEKTC members develop a multicomponent,
quality improvement intervention to deliver among dialy-
sis facilities in order to reduce racial disparities in access to
kidney transplantation. The purpose of this paper is to de-
scribe the community-based participatory research (CBPR)
process used to design the protocol for the RaDIANT
Community Study. The strategy and methods the SEKTC
used to develop a large-scale, evidence-based, quality im-
provement intervention could serve as a model for other
academic or community partnerships in developing and
implementing interventions on the ESRD Network level.
Methods
Study overview
The RaDIANT Community Study is a dialysis facility-
level, randomized clinical trial designed to test the ef-
fectiveness of a multicomponent intervention on im-
proving patient referral for kidney transplantation within
dialysis facilities. Prior to initiation of intervention activ-
ities, the RaDIANT Community Study was registered on
clinicaltrials.gov (Protocol #NCT02092727). This study
was approved by Institutional Review Boards at Emory
Transplant Center, Georgia Regents Kidney and Pancreas
Transplant Program, and Piedmont Transplant Institute
for the collection of retrospective patient referral data, but
no patient contact was made between researchers and
patients.
Target population, setting, and inclusion/exclusion
criteria
Under the direction of Centers for Medicare & Medicaid
Services (CMS), 18 regional ESRD Networks are respon-
sible for the quality of care of patients with kidney dis-
ease in the US. ESRD Network 6 (GA, NC, and SC) has
the largest ESRD patient population among the US
ESRD Networks, servicing more than 600 dialysis facil-
ities that treat ~40,000 patients. Approximately 47% of
the dialysis facilities in ESRD Network 6 are located in
GA, and these facilities treated more than 12,000 dialysispatients in 2012 [47]. The RaDIANT Community Study
aims to target 134 outpatient dialysis facilities in GA,
representing nearly half (47%) of all GA dialysis facilities.
All dialysis facilities within GA were considered for
randomization of the intervention (n = 283). To ensure
that each facility had a large enough population to detect
a change in the main effect of disparity reduction, facil-
ities with a 2012 population of <25 patients (18-69 years
of age) were excluded from the potential pool of facilities
(n = 11). The remaining facilities were selected in a step-
wise selection process: 1) The presence of a racial dis-
parity in transplant referral (n = 75), or 2) crude annual
referral in the lowest 50th percentile (referral <0.06; n = 59)
for the state. The presence of a racial disparity was based
on a difference of the proportion of AA ESRD patients
referred and the proportion of white ESRD patients
referred. The remaining facilities selected had a calculated
crude referral in the lower 50th percentile. The final pool
of 134 facilities were randomized by generating a random
number to either the intervention (n = 67) or control
(n = 67) group (Figure 1). Dialysis facilities in the
intervention group are not blinded to intervention
activities; however, facilities selected as controls are
blinded. Researchers are not blinded to dialysis facility
allocation.
Table 1 reports the characteristics of all dialysis facil-
ities in Georgia (n = 283) and compares characteristics
of the pool of dialysis facilities selected for potential
randomization (i.e., meeting the two-tiered selection cri-
teria) vs. facilities not selected for potential randomization.
A greater proportion of patients within facilities selected
for the RaDIANT Community study (vs. the facilities not
selected) have higher proportions of AA (65.4% vs. 49.0%)
patients compared to GA dialysis facilities not selected for
the study. Dialysis facilities selected for the RaDIANT
Community Study also have a higher proportion of pa-
tients with Medicaid insurance only (11.0% vs. 8.5%),
patients who are unemployed (70.0% vs. 64.1%), and pa-
tients who have hypertension (91.4% vs. 88.1%) com-
pared to facilities not selected for the study (p < 0.05 for
each). As expected, facilities included in the RaDIANT
Community Study have lower likelihood of placement
on the national deceased donor waiting list and kidney
transplant rates, compared to facilities that were not se-
lected for randomization (Table 1).
Study aims & objectives
The primary aim of the RaDIANT Community Study is
to improve referral for kidney transplantation among
AA ESRD patients in GA (primary outcome change in
1-year facility-level referral rate between intervention
and control facilities). The secondary aim of the RaDIANT
Community Study is to evaluate whether the implementa-
tion of this intervention reduced racial disparities in kidney
Figure 1 RaDIANT community study flow diagram for dialysis facility selection.
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Community Study.
Transplant referral data collection
The SEKTC recognized that a major gap in our know-
ledge of transplant disparities was the limited data avail-
able on patient- or facility-level referral for medical
evaluation at a kidney transplant center, a key step in ac-
cess to transplantation. Through our Coalition partners,
we had the unique ability to access data on kidney trans-
plant referrals from the transplant centers in the tri-state
region. As this was the largest collection of transplant
referral data collection to our knowledge, and because
our data suggested that GA had the lowest kidney trans-
plant rates, we chose to start tri-state data collection
among the three adult transplant centers in GA: Emory
Transplant Center (Atlanta, GA), Georgia Regents Kidney
and Pancreas Transplant Program (Augusta, GA), and
Piedmont Transplant Institute (Atlanta, GA). To ensure
consistency of defining referrals, our Coalition partners –
ESRD Network 6 – hosted several conference calls with
CMS and other ESRD Networks that were collecting
transplant referral data as part of the ESRD Network
Statement of Work and Pilot Innovation projects. Part-
ners agreed to define referral as when the transplant
center received the patient’s referral form at the trans-
plant center. The patient-level data collected from each
transplant center included patient age, race/ethnicity,
date of dialysis start, and date of transplant referral,
evaluation, and waitlisting. Referral date was defined as
the date in which the transplant center received a faxed
transplant referral form from a dialysis facility orreferring provider. Each transplant center securely sent
patient-level referral data to ESRD Network 6, which
served as the data coordinating center. ESRD Network
6 linked patient-level referral data with dialysis facility
data by unique provider number using CROWNWeb.
CROWNWeb is a web-based reporting system that al-
lows dialysis facilities to report patient data. Following
linkage with CROWNWeb, deidentified patient data
were then linked to dialysis facility-level demographics
using the publicly available 2012 Dialysis Facility Report
data.
Standard-of-care intervention (Study arm 1)
Dialysis facilities randomized to the standard-of-care
intervention did not receive any specific quality im-
provement interventions related to transplant education.
By law, all dialysis facilities are required to educate pa-
tients about transplantation as a treatment option and
record the assessment of this in the patient’s Medicare
eligibility (CMS-2728) form, although the quantity and
quality of this education is unknown and may vary from
facility to facility.
Multicomponent intervention (Study arm 2)
Based on the results of the population needs assessment,
the SEKTC aimed to develop a sustainable, multicompo-
nent, multi-level quality improvement intervention to
address disparities at the dialysis facility-, staff- and
patient-level. These intervention activities were devel-
oped (or identified) by SEKTC members in face-to-face
and phone conference meetings over several months.
Final intervention activities were selected by the SEKTC
Table 1 Baseline characteristics of dialysis facilities, comparing all dialysis facilities in Georgia, the facilities selected
for randomization, and dialysis facilities not selected for randomization
Facility characteristic Dialysis facilities in
Georgia (n = 283)
Pool of dialysis facilities
randomized for
intervention (n = 134)
Remaining dialysis facilities in
Georgia not selected for
randomization (n = 149)
p-value
Facility Demographic and Clinical Characteristics
# Patients per Facility, Mean, SD 46.0 ± 25.7 46.6 ± 25.5 45.4 ± 26.0 0.57
Number of Staff, Mean, SD 10.0 ± 7.4 10.1 ± 6.5 9.8 ± 8.1 0.48
For Profit, % 90.3 88.7 88.3 0.91
Average Age, Mean, SD 61.4 ± 5.9 61.2 ± 5.7 61.6 ± 6.1 0.76
% White 40.9 33.5 46.8 <0.001
% African American 56.5 65.4 49.0 <0.0001
% Uninsured 12.2 11.5 12.6 0.51
% Medicaid Only 9.1 11.0 8.5 0.01
% Unemployed 67.1 70.9 64.1 0.06
Time on Dialysis (Years), Mean, SD 4.9 ± 1.8 5.0 ± 1.21 4.8 ± 1.1 0.32
% Receiving No Access to Pre-ESRD Nephrology Care 27.3 26.0 28.3 0.28
% Not Informed of Transplant Options 2.8 3.1 2.4 0.28
% Diabetes 59.9 59.9 59.0 0.51
% Hypertensive 89.6 91.4 88.1 0.02
% AV Fistula 13.1 13.8 12.3 0.49
% of Incident Patients with AV Fistula 29.7 28.7 30.5 0.46
Average Count of Comorbidities, Mean, SD 3.0 ± 0.8 3.0 ± 0.8 2.9 ± 0.9 0.30
% ESA Prior to Dialysis 17.6 18.0 18.0 0.25
Standardized Mortality Ratio 1.06 1.07 1.05 0.41
Transplant Access Measures at Baseline
% Waitlisted (Age < 70 yrs only) 17.8 15.5 20.4 <0.0001
Standardized Transplantation Ratio (2008–2011) 0.56 0.46 0.68 <0.001
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sustainability, 3) core tenets of quality improvement in-
terventions, and 4) perception of acceptance among
stakeholders, including dialysis facilities, staff, and pa-
tients, as well as the larger kidney disease community.
The multicomponent, multi-level, quality improvement
intervention targeted to dialysis facilities, staff, and pa-
tients includes educational webinars, staff- and patient-
level educational activities, monthly monitoring of quality
improvement activities, and traditional quality improve-
ment oversight. Because ESRD Network 6 has significant
experience with conducting large quality improvement in-
terventions within dialysis facilities that may be perform-
ing worse than expected for a particular outcome, and
because disparity reduction in transplant referral is part of
the CMS Statement of Work for ESRD Networks [48],
intervention activities are primarily delivered by ESRD
Network 6. The ESRD Network retains the authority to
mandate facility participation in quality improvement ac-
tivities if deemed to have low performance; thus interven-
tions are targeted to dialysis facilities that had either lowoverall kidney transplant referrals or those facilities that
had a racial disparity within their facility (i.e., they had a
lower proportion of AA vs. whites referred for kidney
transplantation).
Intervention activities are designed to target and span
multiple levels, including patient, facility staff, and facility
protocol levels (Figure 2). For example, there are several
interventions that target facility policies and protocols, in-
cluding the requirement that facilities create their own
transplant referral quality improvement plan by journaling
their goals, obstacles, and successes; working with the
ESRD Network on quality improvement assistance and re-
view; creating a patient and family advisory group; con-
ducting a transplant education month; hosting a movie
night including culturally sensitive information about liv-
ing donation; and establishing a peer mentoring program
to help facilitate transplant recipients to speak to potential
transplant candidates. In addition, facilities must report
their monthly referrals to ESRD Network 6 and are given
a baseline and mid-year report on their own facility’s per-
formance related to transplant referral. Facility staff are
Figure 2 Description of patient-, staff-, and facility-level interventions for RaDIANT community study.
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improvement session on improving transplant referrals, at-
tend monthly educational webinars developed by SEKTC
members, attend a transplant educational seminar or ses-
sion across the state (including “Trends in Transplant”
hosted by the Georgia Transplant Foundation, or Explore
Transplant), and complete an online patient safety module.
Educational activities targeting patients within facilities in-
clude bulletin boards that facility staff must set up to edu-
cate patients about transplantation, the opportunity to
participate in the patient and family advisory group for
transplantation, and the receipt of a patient educational
“toolkit” about transplantation. The major intervention ac-
tivities are described in more detail below.
Educational webinars
ESRD Network 6 and various SEKTC members will host
monthly webinars (45- to 55-minute internet educational
seminars), which are intended to serve as a platform for
all parties to discuss potential barriers to kidney trans-
plantation, brainstorm ideas to overcome these obsta-
cles, and celebrate successes. Webinars will cover the
following topics: transplant quality improvement project
overview, review of facility-level baseline transplant re-
ferral data feedback reports, how to establish a patient
mentoring program, education materials for facility staff
and patients, including Explore Transplant [49] and a
shared patient/provider web- and mobile-based decision
aid (iChoose Kidney; described below) that provides in-
dividualized mortality risks comparing dialysis vs. trans-
plantation treatments that was co-developed by SEKTC
partners, and a culturally sensitive DVD targeting the
AA community [(Living About Choices in Transplant-
ation and Sharing (ACTS) [50,51]] detailing the advan-
tages of LD kidney transplantation, financial issues
related to transplantation, a question & answer discus-
sion with transplant center outreach coordinators, a ses-
sion on how staff can give patients an “elevator pitch”about kidney transplantation, a question & answer dis-
cussion with a transplant center medical director, and a
“Patient’s Voice” session, during which transplant recipi-
ents talk about their personal experiences. Email re-
minders for webinar topics will be emailed to the
dialysis facility project lead and project lead alternate
staff member. Participation will be verified for each dia-
lysis facility using a live check-in system; recorded webi-
nars will be available following the live session.
Patient and family educational programs
Implementation of patient and family education programs
will be required at each dialysis facility in order to help in-
form individuals on the benefits of transplantation and in-
formation about how to navigate the transplant process.
Along with dialysis facility-specific education programs,
each facility will be provided with Living ACTS DVD and
an electronic version of the Living ACTS booklet that
could be printed and dispensed to patients and their fam-
ily and help improve their knowledge of kidney transplant
and the benefit of living donation. These materials are
specifically designed for the AA community [51]. Dialysis
facilities will also be encouraged to either develop a men-
toring program that will connect patients and their fam-
ilies to former transplant patients, or utilize the Georgia
Transplant Foundation’s (GTF) established program (the
Dialysis Liaison Program) to match transplant recipients
with dialysis patients within a facility [52]. SEKTC mem-
bers developed a “peer mentoring toolkit” for facilities to
provide recommendations for how mentors should be uti-
lized within the facility to help improve access to kidney
transplantation. A SEKTC partner, Georgia Transplant
Foundation, will aid in tracking utilization of peer mentors
at the facility level.
Transplant referral data reports
Similar to previous quality improvement interventions in
ESRD Network 6 [47,53-55], facilities will receive a
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feedback report detailing their individual facility’s refer-
ral for kidney transplantation, including the overall pro-
portion of patients referred as well as the proportion of
white vs. AA patients referred, based on data reported
from the three transplant centers in GA. The feedback
reports also detail information about low kidney trans-
plant rates and racial disparities in the average time from
dialysis start to referral for ESRD patients in GA
(Figure 3).
Monthly monitoring of transplant referral data
Similar to previous dialysis facility quality improvement
activities, ESRD Network 6 is responsible for monthly
monitoring of the intervention facilities. Facilities will be
required to submit a monthly report of the status of
each patient in their facility, including whether the pa-
tient has been referred for kidney transplantation, and if
so, whether they have been evaluated by the transplant
center, waitlisted, or received a transplant. If the patient
has not been referred, facilities must document the rea-
son. At one year following the intervention, transplant
centers will also report patient-level referral data to val-
idate the monthly, facility-reported referral data and
conduct the outcome evaluation.
Quality improvement assistance and review
Dialysis facility-specific action plans to reduce disparities
and to improve access to kidney transplant referrals will
be a required component of this multicomponent inter-
vention. Facility staff will receive detailed information
(via email) about the core elements of quality improve-
ment, including how to conduct a root cause analysis
and identify a list of potential barriers. ESRD Network
staff members will provide assistance and review of
facility-specific action plans.
Facility leadership and staff-level interventions
At baseline, dialysis facility staff members will be re-
quired to attend an informal orientation reiterating the
importance of transplant. Dialysis facility leadership will
be instructed by the ESRD Network staff members to
host the orientation in order to provide details about the
quality improvement project, but each facility has the
flexibility for how and when they communicate the in-
formation to the facility staff. The orientation allows the
facility to communicate with staff and show their dedica-
tion to improving referral rates, which can ultimately
impact patient outcomes. To emphasize the commit-
ment to improving transplant referrals, staff members
will be encouraged to participate in Georgia Transplant
Foundation’s symposium on “Trends in Transplant”—a
free, educational conference that joins transplant physi-
cians with potential candidates.Patient-level interventions
Facilities will be required to form Patient and Family
Advisory Groups that are focused on increasing trans-
plant referral. The Advisory Group is recommended to
hold regular meetings to discuss referral activities, edu-
cational programs, and patient outreach. Along with the
Advisory Group, patients will be given the opportunity
to collaborate with dialysis facility staff in the creation of
a “Kidney Transplant Toolkit”. This toolkit will give
other dialysis facility patients a comprehensive overview
of the transplant process including where to go for
transplant evaluation, common questions and answers
about the transplant process, potential barriers, and les-
sons learned from transplant recipients. Various educa-
tional resources (that have been previously developed
and are easily accessible online) are included in this tool-
kit, including evidence-based patient education materials.
The iChoose Kidney website and mobile application
(iPhone and iPad tool) is an educational tool available to
patients and their health care staff which uses patient age,
sex, race, time on dialysis, and comorbidities to predict an
individualized risk of mortality if the patient were to re-
main on dialysis vs. to receive a kidney transplant. The
tool presents relative and absolute risks both numerically
and graphically, utilizing best practices for health commu-
nication [56].
Outcome measures
The primary outcome of the RaDIANT Community
Study is the change in facility-level transplant referral
(for patients <70 years) from baseline. Baseline referral
will be calculated as the average number of unique re-
ferrals in a dialysis facility over the 12-month period
preceding the intervention (January-December 2013)
divided by the total number of ESRD patients within the
facility for that time period. Post-intervention crude re-
ferral will be measured as the average number of unique
referrals generated from January-December 2014 divided
by the total number of ESRD patients within the facility
for the same 12 month intervention period. As described
above, referral will be defined as the receipt of a referral
by the transplant center. Patient-level transplant referral
data with facility identifiers will be collected from all of
the transplant centers in GA and aggregated to summarize
the total number of referrals to any transplant center in
the state divided by the total number of adult ESRD pa-
tients <70 years in the facility. If facility characteristics are
not equally distributed at baseline between control and
intervention groups, we will consider adjustment using a
Standardized Transplantation Referral Ratio (STRR). The
STRR will be defined as the total number of observed
transplant referrals within a facility divided by the total
number of expected referrals based on the state average
and adjusting for relevant covariates, among patients aged
Figure 3 Example kidney transplant referral feedback report for dialysis facilities.
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A secondary outcome of interest is the reduction in
AA vs. white racial disparity in transplant referral. The
reduction in racial disparity will be measured as the dif-
ference in the proportion of referrals among AA vs.
whites. Furthermore, we will examine whether the total
number of AA ESRD patients referred for transplant in
the state of GA increased from baseline to 12 months to
examine the absolute impact of the RaDIANT Commu-
nity Study on improving access for AA ESRD patients in
the state.
Other collected variables
Tracking of intervention activities
ESRD Network staff will monitor compliance with pol-
icies and procedures (i.e., forming a Patient and Family
Advisory Committee for transplantation, participation in
monthly webinars, submission of monthly patient-level
facility-reported referral data, etc.) on an at least amonthly
basis. Coalition partners, including Georgia Transplant
Foundation, will monitor facility participation in the Peer
Mentoring program by tracking requests for peer mentors
and peer mentor activities within facilities. Georgia Trans-
plant Foundation and transplant center partners will
monitor facility staff participation in educational activities
across the state, such as Trends in Transplant conferences
and Explore Transplant events.
Patient and dialysis facility staff satisfaction with
intervention activities
To examine feasibility of expanding the intervention out-
side of GA, the SEKTC members, with assistance from
ESRD Network resources, will send an informal email sur-
vey (via survey monkey) to all facility project leadership in
the study to evaluate the fidelity, reach, context, and sus-
tainability of each intervention activity (target n = 134).
To examine the patient impact of the multicomponent
interventions, a sample of patients within dialysis facil-
ities will be surveyed on the relevance, knowledge, and
readiness to pursue transplantation. Process evaluation
data for both facilities and patients are described in
Table 2.
Statistical analyses
Descriptive analyses of facility-level baseline variables
(demographic, clinical characteristics and transplant ac-
cess measures) will be compared and differences be-
tween study arms at baseline will be evaluated using
either t tests or their non-parametric equivalents for
continuous variables and chi-square test for categorical
variables. Significant differences in baseline characteris-
tics will be adjusted when assessing the overall interven-
tion effect as described above.To evaluate the effect of the intervention on improve-
ment in transplant referral by study arm, we will calcu-
late the difference in facility-level transplant referral rate
from baseline to 12 months for each facility in the study.
Analysis of covariance (ANCOVA) will be used to test
for post-intervention mean differences in referral rates
for the control and intervention group after adjusting
for the baseline referral rates and facility characteristics
that differed significantly across the two arms at base-
line. For skewed outcomes, differences in the interven-
tion and control groups will be evaluated using a non-
parametric Wilcoxon rank sum test.
For our secondary outcome, AA vs. white racial dis-
parity in transplant referral, we will examine whether (i)
the proportion of AA patients referred for transplant-
ation increased from baseline to 12 month follow up at
the facility level and (ii) whether there is a differential ef-
fect in the intervention group compared to the control
group over time, after adjusting for between facility het-
erogeneity. A mixed effects model will be used to test
for differences in the proportion of AA patients referred
between baseline and 12-month follow up in the two
study arms respectively. Fixed main effects of (a): time
(measured in months from baseline; baseline assumed
month 0) (b): intervention status (control = 0, interven-
tion = 1), and (c) their interaction on referral disparity,
averaged across different subpopulation of facilities will
be assessed. Facility level random effects (intercepts and
slopes) will be considered to adjust for variations in the
average time trend due to unmeasured confounding in-
dependent of the intervention. If the individual facility
trajectories indicate a similar time trend (slope), a ran-
dom intercept only model will be sufficient to account
for between facility heterogeneity at baseline.
To examine the absolute increase of the intervention
on AA ESRD patient referrals, patient-level logistic re-
gression analysis will be performed with intervention
status, race (AA versus whites) as primary independent
variables and controlling for patient-level baseline char-
acteristics. Because patients are clustered within facil-
ities, we will adjust for the clustering effect. Interactions
between intervention and race will be included to test
for the differential intervention effects by race. For inter-
pretation of findings, we will compare and contrast the
standardized predicted referral rates by racial group within
the intervention and control facilities, respectively.
Power and sample size calculations
Our sample size calculations are based upon our pri-
mary aim to improve access to kidney transplant referral
and also feasibility and resource availability for interven-
tion activities. To test the primary null hypothesis of no
difference in referral proportions between the control
and intervention groups, our sample size of 134 dialysis
Table 2 Process evaluation data for medical directors and ESRD patients within dialysis facilities
Dimension Process evaluation question Measurement
Dialysis Facilities
Fidelity To what extent was the intervention implemented as planned? Checklist of each component of the intervention activity
Reach To what extent did the intervention encourage participation? Number of staff engaged; number of patients participating
in intervention activities
Context What were barriers and facilitators to implementing the intervention
activities?
Open ended item at the end of the form
Sustainability Are you willing to continue the intervention components at your
facility indefinitely?
Yes/No Discrete Response for each intervention activity
ESRD Patients
Participation What was your level of participation in intervention activities? Discrete level of participation item for each component of
the intervention activity
Relevance To what extent was the information offered relevant to you? Checklist of each component of the intervention activity
Knowledge Did the intervention component increase your knowledge about
transplant options?
Self-reported assessment for each intervention component
Readiness To what extent did the intervention component change your
readiness to pursue transplant?
Measure of transplant readiness for each intervention
component
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patients per facility, achieves 80% power to detect a
moderate difference of 3.1% to 4.8% in referral propor-
tions between the two groups at 5% significance level.
The power calculation assumes a 14% crude referral pro-
portion in the control group based on baseline referral
data and an intra-cluster correlation coefficient (ICC) of
0.01 to 0.05, respectively, to account for between-facility
variation.
Discussion
In this paper, we described the formation of an academic–
community partnership; the development of a multicom-
ponent, quality improvement intervention based on results
of a community needs assessment; and the selection of dia-
lysis facilities for the RaDIANT Community Study. Few in-
terventions have been conducted to reduce disparities in
the early steps of the transplant process [12] and, to our
knowledge, no study has described the development of a
large-scale, dialysis facility-level, randomized study to im-
prove transplant referral on a state-wide level and to re-
duce disparities in access to transplantation. This is the
first study that we are aware of that collected transplant re-
ferral data from collaborating transplant centers on a state
level. The detailed description of the development of a
multicomponent intervention could help other ESRD Net-
works, transplant centers, dialysis facilities, or members of
the kidney community to develop similar strategies to im-
prove access to transplantation. In addition, other re-
searchers or community members may find that the
unique academic, community, and government partnership
we utilized in this study protocol may be a feasible way to
utilize sustainable interventions within the community to
reduce health disparities.Reasons for racial disparities are multifactorial and
may include patient, provider, and system factors [8].
Nearly one-third of ESRD patients are not informed of
transplant as a treatment option at the time of ESRD
diagnosis [57], and while AA patients comprise a dispro-
portionate part of the ESRD population, AA patients are
less likely to be informed about transplantation than
white patients [31,32]. This may be particularly import-
ant for our primarily AA ESRD population in the South-
east, where kidney transplant rates are the lowest in the
nation [9]. Systemic, coordinated quality improvement
initiatives targeting dialysis facilities, including arterio-
venous fistula access and influenza vaccination rates
[53], have previously resulted in improved access to
high-quality care for ESRD patients, and similar inter-
ventions may hold promise in reducing disparities in ac-
cess to kidney transplantation.
Community and academic partnerships can be a useful
way to deliver population-based interventions and may
have a high potential for reducing health disparities.
Targeting ESRD regions in the Southeast, the region
with the most racial disparity in transplant access, holds
promise for reducing the overall racial disparity in access
to kidney transplantation [11]. The RaDIANT Commu-
nity Study aims to reach more than one-third of the AA
ESRD patients in GA within nearly half of dialysis facil-
ities in the state with the lowest kidney transplant rate
in the nation. The results of the RaDIANT Community
study could help reduce disparities in access to kidney
transplantation for AA ESRD patients living in the
Southeastern US.
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